全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Probabilistic Description of the Impact of Vaccine-Induced Immunity in the Dynamics of COVID-19 Transmission

DOI: 10.4236/ojmsi.2024.122004, PP. 59-73

Keywords: COVID-19 Transmission Dynamics, Probabilistic Model, Bayesian Analysis, Markov Chain Monte Carlo

Full-Text   Cite this paper   Add to My Lib

Abstract:

The recent outbreak of COVID-19 has caused millions of deaths worldwide and a huge societal and economic impact in virtually all countries. A large variety of mathematical models to describe the dynamics of COVID-19 transmission have been reported. Among them, Bayesian probabilistic models of COVID-19 transmission dynamics have been very efficient in the interpretation of early data from the beginning of the pandemic, helping to estimate the impact of non-pharmacological measures in each country, and forecasting the evolution of the pandemic in different potential scenarios. These models use probability distribution curves to describe key dynamic aspects of the transmission, like the probability for every infected person of infecting other individuals, dying or recovering, with parameters obtained from experimental epidemiological data. However, the impact of vaccine-induced immunity, which has been key for controlling the public health emergency caused by the pandemic, has been more challenging to describe in these models, due to the complexity of experimental data. Here we report different probability distribution curves to model the acquisition and decay of immunity after vaccination. We discuss the mathematical background and how these models can be integrated in existing Bayesian probabilistic models to provide a good estimation of the dynamics of COVID-19 transmission during the entire pandemic period.

References

[1]  World Health Organization (2024) COVID-19 Epidemiological Update-19 January 2024.
https://www.who.int/publications/m/item/covid-19-epidemiological-update---19-january-2024
[2]  World Health Organization (2024) WHO Coronavirus (COVID-19) Dashboard.
https://data.who.int/dashboards/covid19/data
[3]  Flaxman, S., et al. (2020) Estimating the Effects of Non-Pharmaceutical Interventions on COVID-19 in Europe. Nature, 584, 257-261.
https://doi.org/10.1038/s41586-020-2405-7
[4]  Fernández-Recio, J. (2020) Modelling the Evolution of COVID-19 in High-Incidence European Countries and Regions: Estimated Number of Infections and Impact of Past and Future Intervention Measures. Journal of Clinical Medicine, 9, Article 1825.
https://doi.org/10.3390/jcm9061825
[5]  Pérez-Alós, L., et al. (2022) Modeling of Waning Immunity after SARS-CoV-2 Vaccination and Influencing Factors. Nature Communications, 13, Article No. 1614.
https://doi.org/10.1038/s41467-022-29225-4
[6]  Cohen, K.W., et al. (2021) Longitudinal Analysis Shows Durable and Broad Immune Memory after SARS-CoV-2 Infection with Persisting Antibody Responses and Memory B and T Cells. Cell Reports Medicine, 2, Article ID: 100354.
https://doi.org/10.1016/j.xcrm.2021.100354
[7]  Goel, R.R., et al. (2021) mRNA Vaccines Induce Durable Immune Memory to SARS-CoV-2 and Variants of Concern. Science, 374, abm0829.
https://doi.org/10.1126/science.abm0829
[8]  Bayart, J.-L., et al. (2021) Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers. Vaccines, 9, Article 1092.
https://doi.org/10.3390/vaccines9101092
[9]  Hethcote, H.W. (2000) The Mathematics of Infectious Diseases. SIAM Review, 42, 599-653.
https://doi.org/10.1137/S0036144500371907
[10]  Shrotri, M., et al. (2022) Spike-Antibody Responses to COVID-19 Vaccination by Demographic and Clinical Factors in a Prospective Community Cohort Study. Nature Communications, 13, Article No. 5780.
https://doi.org/10.1038/s41467-022-33550-z
[11]  Khoury, D.S., et al. (2023) Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection. Emerging Infectious Diseases, 29, 381-388.
https://doi.org/10.3201/eid2902.221422
[12]  Our World in Data (2023) COVID-19 Vaccine Doses Administered by Manufacturer, European Union.
https://ourworldindata.org/grapher/covid-vaccine-doses-by-manufacturer
[13]  Stein, C., et al. (2023) Past SARS-CoV-2 Infection Protection against Re-Infection: A Systematic Review and Meta-Analysis. The Lancet, 401, 833-842.
https://doi.org/10.1016/S0140-6736(22)02465-5
[14]  Ferdinands, J.M., et al. (2022) Waning of Vaccine Effectiveness against Moderate and Severe COVID-19 among Adults in the US from the VISION Network: Test Negative, Case-Control Study. BMJ, 379, e072141.
https://doi.org/10.1136/bmj-2022-072141

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133